Related Experiment Videos
In vitro pancreatic ductal cell carcinogenesis
Y Ikematsu1, G Liu, M A Fienhold
1The Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha 68198-6805, USA.
International Journal of Cancer
|November 5, 1997
Summary
Carcinogen exposure induced invasive tumors in hamster pancreatic cells, but common oncogene mutations were not essential. Chromosomal changes and immortality, not gene mutations, drove early pancreatic carcinogenesis.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Pancreatic cancer development involves complex biochemical and biological alterations.
- Understanding early changes is crucial for identifying therapeutic targets.
Purpose of the Study:
- To investigate initial molecular and cellular changes during pancreatic carcinogenesis using an in vitro model.
- To determine the role of c-K-ras and p53 mutations in early pancreatic cancer development.
Main Methods:
- Treatment of immortal hamster pancreatic ductal cells (TAKA-1) with N-nitorosobis(2-oxopropyl)amine (BOP).
- Assessing cell growth in soft agar and tumor formation in vivo.
- Analyzing mutations in c-K-ras and p53 oncogenes, chromosomal changes, and expression of TGF-alpha and EGF receptor.
Main Results:
- BOP-treated cells (TAKA-1 + BOP) exhibited anchorage-independent growth and formed invasive tumors in vivo.
- No mutations in c-K-ras or p53 were found in either TAKA-1 or TAKA-1 + BOP cells.
- TAKA-1 + BOP cells showed increased chromosomal abnormalities compared to TAKA-1 cells.
Conclusions:
- C-K-ras and p53 mutations are not essential for initiating pancreatic carcinogenesis in this hamster model.
- Cellular immortality and chromosomal alterations appear to be key early events in BOP-induced pancreatic carcinogenesis.
- TGF-alpha expression in immortal cells mimics that of malignant cells, suggesting its role in early stages.